AM Policy Update: March 15, 2026
The DEA scheduling cannabis policy update on March 15, 2026, highlights key regulatory changes affecting cannabis medicine. This includes temporary placements and rescheduling of substances relevant to controlled substances regulations. Understanding…
AM Study Update: March 15, 2026
This AM Study Update presents cannabis clinical trials evidence from March 15, 2026, focusing on recent research findings. The report covers safety and efficacy data for various cannabis therapies. Clinicians can use this evidence to inform patient care…
AM News Update: March 15, 2026
This cannabis news update for March 15, 2026, covers key developments in cannabis research and legislation. Highlights include studies on CBD and CBG for fatty liver disease and regulatory updates. Stay informed with the latest cannabis news update…
Cannabinoid Clinical Trials: CBD & Cortical Excitability Insights
This clinical trial investigates CBD anti seizure properties and their impact on cortical excitability. Results suggest CBD alone does not significantly alter cortical excitability. The study emphasizes the role of pharmacokinetic interactions in seizure…
Cannabinoid Clinical Trials: EEG Sleep Insomnia Study
This cannabinoid clinical trials sleep study examined THC and CBD effects on EEG sleep in adults with insomnia. The trial found reduced total sleep time and altered REM sleep with cannabinoids. These findings highlight the need for further research on…
Cannabinoid Clinical Trials: CBD for Fibromyalgia Evidence
This article reviews cannabidiol clinical trials fibromyalgia evidence assessing CBD's efficacy. The trials show no significant superiority of CBD over placebo in reducing fibromyalgia pain. Understanding this evidence helps clinicians advise patients…
Endocannabinoid System & Adolescent Health: Clinical Evidence
This 15-year longitudinal adolescent health study reveals how early psychosocial risk factors impact adult mental health and substance use outcomes. The research highlights the importance of early screening for disordered eating and body image concerns.…
Effectiveness of the Minder Mobile App for Student Mental Health
The Minder mobile mental health RCT tested a student-codeveloped app to improve mental health and substance use outcomes in university students. This randomized controlled trial provides evidence on the efficacy of digital interventions during the…
Cannabinoids & Athlete Mental Health: Clinical Evidence
Retired professional athletes face unique mental health challenges, including depression and anxiety. Cannabinoid clinical trials athlete mental health research explores potential therapeutic roles. Understanding this evidence helps guide clinical…
Endocannabinoid System Research: Cannabinoids in Children
Cannabinoids for pediatric medicine clinical evidence review reveals a growing body of research on safety and benefits in children. Studies include controlled trials and observational data across various conditions. This review helps clinicians weigh…